Cell proliferation inhibition and antitumor activity of novel alkyl series of diorganotin(IV) compounds

Journal of Applied Toxicology

Volumn 28, Issue 4, 2008, Pages 430-438

  Koch, Biplob ^a   Basu Baul, Tushar S ^a   Chatterjee, Anupam ^a  

^a NORTH EASTERN HILL UNIVERSITY   (India)

Author keywords

Antiproliferation; Antitumor; Diorganotin(IV); DNA damage

Indexed keywords

GLUTATHIONE; ORGANOTIN COMPOUND; PROTEIN P16; PROTEIN P53;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER SCREENING; CELL CYCLE PROGRESSION; CELL PROLIFERATION; CHROMOSOME ABERRATION; CONTROLLED STUDY; DRUG INHIBITION; HUMAN; HUMAN CELL; LYMPHOCYTE; LYMPHOMA; MALE; MOUSE; NONHUMAN; NORMAL HUMAN; PRIORITY JOURNAL; SISTER CHROMATID EXCHANGE; TRANSPLANTATION;

ANIMALS; ANTINEOPLASTIC AGENTS; BLOTTING, WESTERN; CELL CYCLE; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; CRYSTALLOGRAPHY, X-RAY; GLUTATHIONE; HUMANS; LYMPHOCYTES; LYMPHOMA; MALE; MICE; MOLECULAR STRUCTURE; ORGANOTIN COMPOUNDS; SISTER CHROMATID EXCHANGE; STRUCTURE-ACTIVITY RELATIONSHIP; TIME FACTORS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 44149120271     PISSN: 0260437X     EISSN: 10991263     Source Type: Journal    
DOI: 10.1002/jat.1290     Document Type: Article

References (37)

1. Al-Imara L, Salaman MR, Sljivic VS, Poller RC. 1993. Inhibition of mouse spleen cell activity by organotin compounds: effect of attachment to a maltose residue to the organotin group. Int. J. Immunopharmacol. 15: 287-291.
2. 4=N-(2- pyridylmethylene)-4-toluidine]. Appl. Organometal. Chem. 12: 503-513.
3. 2Sn, Z. Kristallogr. (NCS) 214: 207-208.
4. 2Sn. Z. Kristallogr. (NCS) 214: 209-210.
5. 2Sn. Z. Kristallogr. (NCS) 214: 211-212.
6. Caruso F, Bol-Schoenmakers M, Penninks AH. 1993. Crystal and molecular structure and in vitro antiproliferation and antitumor activity of two organotin (IV) carbohydrate compound. J. Med. Chem. 36: 1168-1174.
7. 3-oxobis[μ- chlorodiethyltin(IV)]-bis[o-chlorodiethyltin(IV)] and 2,2′-bipyridyl. J. Organometal. Chem. 202: 247-256.
8. Cookson MR, Slamon ND, Pentreath VW. 1998. Glutathione modifies the toxicity of triethyltin and trimethyltin in C6 glioma cells. Arch. Toxicol. 72: 197-202.
9. Crowe AJ. 1987. The chemotherapeutic properties of Tin compounds. Drugs Future 12: 255-275.
10. Crowe AJ, Smith PJ, Atassi G. 1984a. Investigations into the antitumor activity of organotin compounds. 2. Diorganotin dihalide and dipseudohalide complexes. Inorg. Chim. Acta 93: 179-184.
11. Crowe AJ, Smith PJ, Cardin CJ, Parge HE, Smith FE. 1984b. Possible predissociation of diorganotin dihalide complexes - relationship between antitumor activity and structure. Cancer Lett. 24: 45-58.
12. De Santiago A, Aguilar-Santelises M. 1999. Organotin compounds decrease in vitro survival, proliferation and differentiation of normal human B lymphocytes. Hum. Exp. Toxicol. 18: 619-624.
13. Gennari A, Potters M, Seinen W, Pieters R. 1997. Organotin-induced apoptosis as observed in vitro is not relevant for induction of thymus atrophy at antiproliferative doses. Toxicol. Appl Pharmacol. 147: 259-266.
14. 50Sn Tin Compounds and Their Therapeutic Potential. Wiley: Chichester; 421-439.
15. Gielen M, Willem R, Bouhdid A, De Vos D, Kuiper CM, Veerman G, Peters GJ. 1995. In vitro antiproliferation effects, toxicity profiles in vivo in mice and antitumor activity in tumor bearing mice of five diorganotin compounds. In Vivo 9: 59-64.
16. Goto K, Akematsu T, Shimagu H, Suigiyama T. 1975. Simple differential Giemsa staining of sister chromatids after treatment with photosensitive dyes and exposure to light and the mechanism of staining. Chromosoma 53: 223-230.
17. Harper JW, Adami G, Wel N, Keyomarsi K, Elledge S. 1993. The p21 cdk-interacting protein Cip1 is apotent inhibitor of G1 cyclin-dependent kinases. Cell 75: 805-816.
18. Ishii Y, Bender MA. 1982. Effects of inhibitors of DNA synthesis on spontaneous and ultra-violet light induced sister chromatid exchanges in Chinese hamster cells. Mutat. Res. 79: 19-32.
19. Khilman BA. 1977. Caffeine and Chromosomes. Elsevier: Amsterdam.
20. Kohn KW, Shao RG, Pommier Y. 2000. How do drug-induced topoisomeraseI-DNA lesions signal to the molecular interaction network that regulates cell cycle checkpoints, DNA replication and DNA repair? Cell Biochem. Biophys. 33: 175-180.
21. Kuerbitz SJ, Plunkett BS, Walsh WV, Kastan MB. 1992. Wild-type p53 is a cell cycle checkpoint following irradiation. Proc. Natl Acad. Sci. USA 89: 7491-7495.
22. Loehrer PJ, Einhorn LH. 1984. Drugs five years later. Cisplatin. Ann. Intern. Med. 100: 704-713.
23. MacRae WD, MacKinnon EA, Stich HF. 1979. The fate of UV-induced lesions affecting SCEs, chromosome aberrations and survival of CHO cells arrested by deprivation of arginine. Chromosoma 72: 15-22.
24. McFee AF, Sayer AM, Salomaa SI, Lindholm C, Littlefield LG. 1997. Methods for improving the yield and quality of metaphase preparations for FISH probing of human lymphocyte chromosomes. Environ. Mol. Mutagen. 29: 98.
25. n+ complexes formed with biologically active ligands: equilibrium and structural studies, and some biological aspects. Coordination Chem. Rev. 224: 111-150.
26. Pieters RH, Bol M, Seinen W, Penninks AH. 1994. Cellular and molecular aspects of organotin-induced thymus atrophy. Hum. Exp. Toxicol. 13: 876-879.
27. Rekker RF. 1977. The Hydrophobic Fragmental Constant. Elsevier: Amsterdam.
28. Rudoltz MS, Kao G, Blank KR, Muschel RJ, McKenna WG. 1996. Molecular biology of the cell cycle: Potential for therapeutic applications in radiation oncology. Semin. Radiat. Oncol. 6: 284-294.
29. Santiago A De, Aguilar-Santelises M. 1999. Organotin compounds decrease in vitro survival, proliferation and differentiation of normal human B lymphocytes. Hum. Exp. Toxicol. 18: 619-624.
30. Schneider Y, Chabert P, Stutzmann J, Coelho D, Fougerousse A, Gosse F, Launay JF, Brouillard R, Raul F. 2003. Resveratrol analog (Z)-3,5,4′- trimethoxystibene is a potent anti-mitotic drug inhibiting tubulin polymerization. Int. J. Cancer 107: 189-196.
31. Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner FH, Provenzano MD, Fujimoto EK, Goeke NM, Olson BJ, Klenk DC. 1985. Measurement of protein using bicinchoninic acid. Anal. Biochem. 150: 76-85.
32. Stridh H, Orrenius S, Hampton MB. 1999. Caspase involvement in the induction of apoptosis by the environmental toxicants tributyltin and triphenyltin. Toxicol. Appl. Pharmacol. 156: 141-146.
33. Syng-ai C, Basu Baul T, Chatterjee A. 2001. Inhibition of cell proliferation and antitumor activity of a novel organotin compound. J. Environ. Pathol. Toxicol. Oncol. 20: 333-342.
34. Syng-ai C, Basu Baul T, Chatterjee A. 2002. Antiproliferative and cytotoxic effect of a novel organotin compound on mammalian cells both in vitro and in vivo. Mutat. Res. 513: 49-59.
35. TEXAN. 1995. Single crystal structure analysis software. Version 1.7.1. Molecular structure corporation. The Woodlands, TX, USA.
36. Thompson TA. 1996. Induction of apoptosis by organotin compounds in vitro: Neuronal protection with antisense oligonucleotides directed against stannin. J. Pharmacol. Exp. Ther. 276: 1201-1215.
37. Zhou J, Prives C. 2003. Replication of damaged DNA in vitro blocked by p53. Nucleic Acids Res. 31: 3881-3892.